SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch SUPN
See up to 3 months of SUPN. The 7-day demo opens the 1M and 3M ranges and puts SUPN on your watchlist.
Start 7-day demoLatest SUPN insider trades
About SUPERNUS PHARMACEUTICALS, INC. (SUPN)
SUPERNUS PHARMACEUTICALS, INC. files with the SEC under CIK 0001356576 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
SUPN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 5 | 35,999 | |
| Option exercise | 10 | 71,998 | |
| Tax withholding / forfeiture | 5 | 15,564 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
SUPN insider transactions (Form 4)
8785 Form 4 filings on record, the earliest from Nov 8, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Frank Mottola - Officer | Grant or award | Common Stock | 1,125 | $0.00 | - | |
| Frank Mottola - Officer | Grant or award | Common Stock | 750 | $0.00 | - | |
| Frank Mottola - Officer | Grant or award | Common Stock | 1,250 | $0.00 | - | |
| Frank Mottola - Officer | Tax withholding / forfeiture | Common Stock | 603 footnote F1 | $51.35 | $31K | |
| Frank Mottola - Officer | Tax withholding / forfeiture | Common Stock | 368 footnote F1 | $50.86 | $19K | |
| Frank Mottola - Officer | Tax withholding / forfeiture | Common Stock | 670 footnote F1 | $50.86 | $34K | |
| Frank Mottola - Officer | Derivative | Restricted Stock Unit | 1,125 | $0.00 | - | |
| Frank Mottola - Officer | Derivative | Restricted Stock Unit | 750 | $0.00 | - | |
| Frank Mottola - Officer | Derivative | Restricted Stock Unit | 1,250 | $0.00 | - | |
| ||||||
| Jonathan Rubin - Officer | Grant or award | Common Stock | 1,125 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Common Stock | 750 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Common Stock | 1,250 | $0.00 | - | |
| Jonathan Rubin - Officer | Tax withholding / forfeiture | Common Stock | 603 footnote F1 | $51.35 | $31K | |
| Jonathan Rubin - Officer | Tax withholding / forfeiture | Common Stock | 369 footnote F1 | $50.86 | $19K | |
| Jonathan Rubin - Officer | Tax withholding / forfeiture | Common Stock | 671 footnote F1 | $0.00 | - | |
| Jonathan Rubin - Officer | Derivative | Restricted Stock Unit | 1,125 | $0.00 | - | |
| Jonathan Rubin - Officer | Derivative | Restricted Stock Unit | 750 | $0.00 | - | |
| Jonathan Rubin - Officer | Derivative | Restricted Stock Unit | 1,250 | $0.00 | - | |
| ||||||
| Georges Gemayel - Director | Option exercise | Common Stock | 15,000 | $12.98 | $195K | |
| Georges Gemayel - Director | Grant or award | Common Stock | 4,475 | $0.00 | - | |
| Georges Gemayel - Director | Option exercise | Director Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Georges Gemayel - Director | Derivative | Restricted Stock Unit | 4,475 | $0.00 | - | |
 Bethany Sensenig - Director | Option exercise | Common Stock | 4,475 | $0.00 | - | |
| Bethany Sensenig - Director | Open-market sale | Common Stock | 3,258 | $51.27 footnote F3 | $167K | |
| Bethany Sensenig - Director | Open-market sale | Common Stock | 1,217 | $50.31 footnote F2 | $61K | |
| Bethany Sensenig - Director | Option exercise | Restricted Stock Unit | 4,475 | $0.00 | - | |
| ||||||
| Timothy C. Dec - Officer | Grant or award | Employee Stock Option (Right to Buy) | 17,500 | $0.00 | - | |
| Timothy C. Dec - Officer | Grant or award | Restricted Stock Unit | 3,000 | $0.00 | - | |
| Padmanabh P. Bhatt - Officer | Grant or award | Employee Stock Option (Right to Buy) | 13,500 | $0.00 | - | |
| Padmanabh P. Bhatt - Officer | Grant or award | Restricted Stock Unit | 3,000 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Employee Stock Option (Right to Buy) | 13,500 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Restricted Stock Unit | 3,000 | $0.00 | - | |
| Frank Mottola - Officer | Grant or award | Employee Stock Option (Right to Buy) | 13,500 | $0.00 | - | |
| Frank Mottola - Officer | Grant or award | Restricted Stock Unit | 3,000 | $0.00 | - | |
| Jack A. Khattar - Officer | Grant or award | Employee Stock Option (Right to Buy) | 341,610 | $0.00 | - | |
| Georges Gemayel - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Georges Gemayel - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
 Carrolee Barlow - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Carrolee Barlow - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
| Bethany Sensenig - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Bethany Sensenig - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
| Charles W. Newhall III - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Charles W. Newhall III - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
 Frederick M. Hudson - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Frederick M. Hudson - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
| Charles W. Newhall III - Director | Option exercise | Common Stock | 15,000 | $12.98 | $195K | |
| Charles W. Newhall III - Director | Option exercise | Director Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Padmanabh P. Bhatt - Officer | Grant or award | Performance Share Unit | 1,500 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 81,250 | $25.30 | $2.06M | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 58,371 | $50.55 footnote F2 | $2.95M | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 1,529 | $51.46 footnote F3 | $79K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 81,250 | $0.00 | - | |
| ||||||
| Charles W. Newhall III - Director | Open-market sale | Common Stock | 23,800 | $50.73 footnote F2 | $1.21M | |
| Charles W. Newhall III - Director | Open-market sale | Common Stock | 1,200 | $51.55 footnote F3 | $62K | |
| ||||||
| Jack A. Khattar - Officer | Option exercise | Common Stock | 2,267 | $25.30 | $57K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 1,904 | $48.06 footnote F2 | $92K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 2,267 | $0.00 | - | |
| ||||||
| Jack A. Khattar - Officer | Option exercise | Common Stock | 53,785 | $25.30 | $1.36M | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 40,173 | $48.07 footnote F2 | $1.93M | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 53,785 | $0.00 | - | |
| ||||||
| Jack A. Khattar - Officer | Option exercise | Common Stock | 11,510 | $25.30 | $291K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 8,588 | $48.25 | $414K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 11,510 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 13,688 | $25.30 | $346K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 10,235 | $48.02 | $491K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 13,688 | $0.00 | - | |
| Jonathan Rubin - Officer | Option exercise | Common Stock | 1,875 | $0.00 | - | |
| Jonathan Rubin - Officer | Tax withholding / forfeiture | Common Stock | 840 | $46.21 | $39K | |
| Jonathan Rubin - Officer | Option exercise | Performance Share Unit | 1,875 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 47,940 | $12.98 | $622K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 29,513 | $47.23 | $1.39M | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 47,940 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 27,060 | $12.98 | $351K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 16,587 | $47.02 | $780K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 27,060 | $0.00 | - | |
| Frank Mottola - Officer | Option exercise | Common Stock | 5,000 | $39.40 | $197K | |
| Frank Mottola - Officer | Open-market sale | Common Stock | 5,000 | $45.87 | $229K | |
| Frank Mottola - Officer | Option exercise | Employee Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Performance Share Unit | 1,875 | $0.00 | - | |
| Jack A. Khattar - Officer | Grant or award | Performance Share Unit | 20,000 | $0.00 | - | |
| Jack A. Khattar - Officer | Grant or award | Performance Share Units | 19,320 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 8,074 | $25.30 | $204K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 6,322 | $46.29 | $293K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 8,074 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 73,176 | $25.30 | $1.85M | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 55,578 | $46.01 | $2.56M | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 73,176 | $0.00 | - | |
Item 8.01, 9.01
Item 8.01, 9.01
Item 2.02, 9.01
Item 1.01, 5.02, 8.01, 9.01
Stock trades in SUPN disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
SUPN insider trading FAQ
What is the latest insider trade for SUPN?
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had 10 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for SUPN runs to 85 Form 4 filings, the earliest from 2024-11-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SUPN stock?
No insider purchases of SUPN were filed in the last 90 days.
How many insiders are selling SUPN stock?
No insider sales of SUPN were filed in the last 90 days. 53 sales are on record for this company.
Where can I see SUPN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SUPN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jack A. Khattar view on EDGAR
- - Jonathan Rubin view on EDGAR
- - Padmanabh P. Bhatt view on EDGAR
- - Frank Mottola view on EDGAR
- - Timothy C. Dec view on EDGAR
- - Jack A. Khattar view on EDGAR
- - Timothy C. Dec view on EDGAR
- - Frank Mottola view on EDGAR
- - Padmanabh P. Bhatt view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SUPN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SUPN with a 7-day demo
- SUPN on your watchlist
- Every SUPN Form 4 filing on record
- Up to 3 months of SUPN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
